Stock Market & Financial News

Loading...
Solana Climbs to Mid-$70s as Tokenization Growth Draws Institutional Interest

Solana Climbs to Mid-$70s as Tokenization Growth Draws Institutional Interest

Solana (SOL) climbed back into the mid-$70 range on Monday, leading a broader altcoin rebound as traders pointed to rising 'institutional adoption' and a growing pipeline of 'tokenized assets' on the network as key supports for demand. As of around 9:00 p.m.

SOLUSD
Tokenpost | 2 weeks ago

Gold's $4,000 skirmish continues as it eyes worst quarter in 13 years

The precious metal may have the calendar on its side, according to an analyst

Goldman Sachs Physical Gold ETF logo AAAU
Marketwatch | 2 weeks ago

SiriusPoint: The Turnaround Is Over, But The Valuation Hasn't Caught Up

SiriusPoint has evolved from a turnaround story into a disciplined specialty insurer with a significantly lower-risk underwriting profile. Continued reductions in catastrophe exposure are making earnings more durable rather than simply boosting one quarter's results. Capital allocation has shifted from balance sheet repair toward buybacks, preferred share redemptions, and long-term shareholder value creation.

SiriusPoint Ltd. logo SPNT
Seekingalpha | 2 weeks ago

eToro Group: Users Are Rotating, Not Leaving

eToro Group Ltd. (ETOR) remains a buy as its multi-asset platform demonstrates resilience and user stickiness beyond crypto cycles. ETOR's Q1 2026 saw 12% y/y funded account growth and 15% y/y AUA growth, with commodities driving a fourfold increase in trading volumes. ETOR's expanding product suite, including 24/7 trading and wealth products, aims to deepen user engagement and diversify monetization.

eToro Group Ltd. logo ETOR
Seekingalpha | 2 weeks ago
XRP Holds Near $1 as ETF Inflows Rise but Resistance Limits Breakout

XRP Holds Near $1 as ETF Inflows Rise but Resistance Limits Breakout

XRP (XRP) traded in a tight range around $1.04 on Monday, with investors closely watching whether the token can defend the psychologically important $1.00 level and reclaim key resistance zones that could signal a broader trend shift. While signs of steady 'institutional demand' are emerging through fund flows and on-chain activity, technicians say a sustainable rebound still hinges on a clean break above overhead resistance.

XRPUSD
Tokenpost | 2 weeks ago
Best Value Stocks to Buy for June 30th

Best Value Stocks to Buy for June 30th

HG, DFIN and EFXT made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 30, 2026.

Donnelley Financial Solutions Inc. logo DFIN
Zacks | 2 weeks ago
Tether Advisor Gurbacs Breaks Down 'a Big Reason' Why Bitcoin Is Not at All-Time High

Tether Advisor Gurbacs Breaks Down 'a Big Reason' Why Bitcoin Is Not at All-Time High

Bitcoin is still trading below half of its all-time high price record, while the S&P 500, QQQ and gold continue to regularly set new records. The key reason for this prolonged underperformance was formulated by Tether adviser Gabor Gurbacs.

BTCUSD
U | 2 weeks ago
Singapore court grants $3M to Terraform UST collapse victims

Singapore court grants $3M to Terraform UST collapse victims

Singapore court has awarded more than $3 million in damages to 40 investors after finding Terraform Labs and co-founder Do Kwon liable for fraudulent misrepresentations tied to the 2022 TerraUSD collapse.

USTUSD
Crypto | 2 weeks ago
Micron: AI Momentum Keeps The Bull Case Intact

Micron: AI Momentum Keeps The Bull Case Intact

Micron (MU) remains a beneficiary of sustained AI-driven memory demand, though valuation is less compelling after a significant run-up. Current memory shortages are expected to persist, with hyperscalers and AI adoption driving robust demand and long-term contracts reducing near-term risk. MU trades at 12x–14x 2030 EPS estimates, with buybacks prioritized to return capital; cyclical risks and innovation-driven disruption remain key considerations.

Micron Technology, Inc. logo MU
Seekingalpha | 2 weeks ago
Genmab Shares Climb After Lymphoma Therapy Hits Goal in Trial

Genmab Shares Climb After Lymphoma Therapy Hits Goal in Trial

The Danish biotechnology company and partner AbbVie said a drug combination to treat lymphoma met the primary goal in a late-stage clinical trial.

Genmab A/S Sponsored ADR logo GMAB
Wsj | 2 weeks ago

Doximity: Everyone Is Focused On The Guidance While Missing The Valuation And AI Stories

Doximity issued conservative FY2027 guidance, projecting 4% revenue growth and a 49% adjusted EBITDA margin, triggering a post-earnings stock selloff. I view the selloff as a temporary dislocation and a compelling buying opportunity for value investors given DOCS's resilient core platform usage. Management emphasized record physician engagement and continued dominance of DOCS's core products despite macroeconomic and regulatory headwinds.

Doximity Inc. logo DOCS
Seekingalpha | 2 weeks ago

Silver price today: Silver rises, according to FXStreet data

Silver price today: Silver rises, according to FXStreet data

XAGU
XAGUSD
Fxstreet | 2 weeks ago

Trump's Bitcoin made in America push runs into a power problem the tax bill cannot fix

Congress is moving to fix how the US tax code treats crypto mining and staking rewards, and for validators and their institutional clients, the fix is long overdue. H.R.

BTCUSD
Cryptoslate | 2 weeks ago

Best Growth Stocks to Buy for June 30th

DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 30, 2026.

DaVita Inc. logo DVA
Zacks | 2 weeks ago

Comcast's Breakup Is Overdue. It Shouldn't Rush Into a New Marriage.

The case for bundling media with distribution has weakened in the streaming era, but further M&A makes less sense.

Comcast Corp logo CMCSA
Wsj | 2 weeks ago

Carl Rinsch sentenced to 30 months for misusing Netflix funds on Dogecoin

The case underscores the legal risks of unauthorized crypto investments and highlights the importance of accountability in financial dealings. Carl Rinsch sentenced to 30 months for misusing Netflix funds on Dogecoin.

DOGEUSD
Cryptobriefing | 2 weeks ago

H.B. Fuller Q2 Earnings Call Flags Pricing, AMS Ambitions

FUL flags stronger pricing, higher profit guidance and a proposed AMS deal aimed at expanding its medical adhesives platform and boosting margins.

American Shared Hospital Services logo AMS
Zacks | 2 weeks ago

Strait of Hormuz is reopening faster than expected, says Morgan Stanley as it cuts oil-price target

The Strait of Hormuz is reopening faster than expected, oil analysts at Morgan Stanley said as they cut their oil-price view for this year and next.

Morgan Group Holding Co. logo MGHL
Marketwatch | 2 weeks ago

Entain and Rank fall on report that Burnham could hike gambling machine taxes

Shares in Ladbrokes and Coral owner Entain PLC (LSE:ENT) and Grosvenor casino owner Rank Group PLC (LSE:RNK) fell after a report that slot machine shops and casinos could face a £460 million tax rise under a future Labour government led by Andy Burnham. According to the Guardian, the Social Market Foundation has proposed doubling machine games duty from 20% to 40% on higher-stakes Category B machines, which allow £2 spins every 2.5 seconds.

Entain plc logo GMVHF
Proactiveinvestors | 2 weeks ago

Ethereum price risks lower low as ETH struggles near $1,500

Ethereum trades near $1,580 as monthly support weakens, ETF outflows persist and leverage resets across major derivatives markets this week.

ETHUSD
Crypto | 2 weeks ago

'47 Ronin' Director Gets 30 Months for Spending Netflix's $11M on Dogecoin

Carl Rinsch gambled Netflix's $11 million on stock options and Dogecoin, then spent the winnings on luxury cars and watches.

DOGEUSD
Decrypt | 2 weeks ago

Seagate: Mass Capacity HDD Is Having Its Moment (Rating Downgrade)

Seagate Technology surged 241% since my last coverage, dramatically outperforming the benchmark's 7%. I remain bullish on STX, citing revolutionary AI-driven demand and ongoing catalysts in the data center and memory markets. I downgrade STX to Buy from Strong Buy, as much of the upside may be reflected in the current price.

Seagate Technology Holdings plc logo STX
Seekingalpha | 2 weeks ago

Ford to recall over 741,000 US vehicles due to park system issue, NHTSA says

Ford is recalling 741,195 vehicles in the US ​over a transmission defect that can ‌damage the park system, which in turn could result in vehicles rolling away, the US ​National Highway Traffic Safety Administration said ​on Tuesday.

Ford Motor Company logo F
Nypost | 2 weeks ago

Quant funds suffer their worst trading rout of the year as momentum bets unwind

The recent quant fund losses highlight the risks of crowded trades, challenging their appeal as uncorrelated investments for portfolios. Quant funds suffer their worst trading rout of the year as momentum bets unwind.

QNTUSD
Cryptobriefing | 2 weeks ago

SM Energy: Don't Believe The Fear, Buy The Upside Instead

SM Energy is rated Strong Buy, trading at a 70% sector discount despite robust asset growth and operational improvements. Recent mergers and acquisitions, notably Civitas and Uinta Basin, have expanded SM's asset base to 800,000 net acres, boosting oil and NGL output. Derivative losses, primarily inherited from Civitas, temporarily cap crude upside but are expected to reverse by 2027, unlocking further value.

SM Energy Company logo SM
Seekingalpha | 2 weeks ago

Accenture: Betting On Stability, Not Growth

Accenture (ACN) trades at historically low valuations, with a forward P/E of 9.3 and forward P/FCF below 8, despite its strong cash generation. I see valid AI-related risks, but ACN's early pivot to AI, strategic acquisitions, and ecosystem partnerships position it better than peers to adapt. Recent acquisitions in cybersecurity are expensive but strategically diversify ACN's revenue mix and support its non-FTE business model ambitions.

Accenture plc Class A logo ACN
Seekingalpha | 2 weeks ago

Nvidia's culture of frugality extends all the way to the cafeteria

Nvidia pays exceptionally well. Just don't expect free lunch.

NVIDIA Corporation logo NVDA
Businessinsider | 2 weeks ago

Medicare will start covering obesity drugs for the first time. Here's what patients should know

Starting Wednesday, eligible seniors with Medicare coverage can access GLP-1s for obesity with a copay of just $50 per month through a temporary program called Bridge. The move could unlock a vast new patient population for Novo Nordisk and Eli Lilly and dramatically expand access to medications that were previously out of reach for many older Americans.

Novo Nordisk A/S Sponsored ADR logo NVO
Cnbc | 2 weeks ago

Gold: Deeper pullback eyes October lows – Societe Generale

Gold: Deeper pullback eyes October lows – Societe Generale

XAUU
XAUUSD
Fxstreet | 2 weeks ago

Digital Realty falls 4% after taking $3.5 billion stake in Blackstone's Virginia data centers

Digital Realty said Tuesday is purchasing a $3.5 billion stake in three data centers from Blackstone. The global data center firm fell in premarket trading following the announcement.

Blackstone Inc. logo BX
Cnbc | 2 weeks ago
Load More
Loading...